Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg
You Searched
Polyday 1 mg/500 mg/0.2 mg Tablet
₹90
Our Recommendation
Vogeab GM 1/500/0.2mg Tablet 10s
1,128+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
In Treatment of Type 2 diabetes mellitus Polyday 1 mg/500 mg/0.2 mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. Polyday 1 mg/500 mg/0.2 mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Polyday 1 mg/500 mg/0.2 mg Tablet is to be taken empty stomach.
Polyday 1 mg/500 mg/0.2 mg Tablet is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.
Unsafe: Avoid consuming alcohol with Polyday 1 mg/500 mg/0.2 mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Polyday 1 mg/500 mg/0.2 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Polyday 1 mg/500 mg/0.2 mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Caution Advised: Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Not Safe: Polyday 1 mg/500 mg/0.2 mg Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Doctor consultation is advised. Use of Polyday 1 mg/500 mg/0.2 mg Tablet is, however, not recommended in patients with severe kidney disease.
Caution Advised: Polyday 1 mg/500 mg/0.2 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Polyday 1 mg/500 mg/0.2 mg Tablet may be needed. Doctor consultation is advised. Polyday 1 mg/500 mg/0.2 mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
If a dose of Polyday 1 mg/500 mg/0.2 mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India
Glimepiride (08 Apr. 2019)
Metformin hydrochloride (08 Apr. 2019)
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)
Glimepiride+Metformin+Voglibose (25 Oct. 2021)
Metformin Hydrochloride (Prolonged Release), Voglibose & Glimepiride (28th Sept. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.